Peter Altman

CEO, BioCardia

Peter A. Altman, Ph.D. has served as BioCardia (OTC: BCDA) CEO since 2002, where he has global responsibility for the development, manufacture and marketing of our therapeutic candidates and products. He was founding CEO from 1999 to 2003 and board member 1999 to 2014of CareDx (NASDAQ: CDNA) , a developer of a gene based diagnostics to be used for transplantation management. He was also founding CEO for Lumen Therapeutics from 2004 to 2005, an early-stage pharmaceutical company. He received his Ph.D. in Bioengineering/Pharmaceutical Chemistry from the University of California, San Francisco and University of California, Berkeley, his Management of Technology certificate from the Walter A. Haas School of Business at the University of California, Berkeley, and both his Master of Science and Bachelor of Science in Mechanical Engineering from the Columbia University School of Engineering and Applied Science.